Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00918645 · ClinicalTrials.gov registry record · NA
Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis
A NA study, sponsored by University of California, Davis.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00918645 is a NA study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 13 participants.
The verdict
NCT00918645, a NA study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as radionuclide imaging using calcium-41 (41Ca) chloride aqueous solution, may help predict progressive disease in patients with prostate cancer and bone metastasis. PURPOSE: This clinical trial is studying how well calcium-41 (41Ca) chloride aqueous solution works in diagnosing patients with prostate cancer and bone metastasis.
Interventions
- DRUG 41 Ca
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00918645
The ClinicalTrials.gov registry entry for NCT00918645 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 41 Ca is the first listed.
NCT00918645 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00918645 about?
NCT00918645 is a clinical study titled "Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis". RATIONALE: Diagnostic procedures, such as radionuclide imaging using calcium-41 (41Ca) chloride aqueous solution, may help predict progressive disease in patients with prostate cancer and bone metastasis. PURPOSE: This clinical trial is studying how well calcium-41 (41Ca) chloride aqueous solution ...
What is the current status of trial NCT00918645?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2009-09. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00918645?
The interventions under investigation include: 41 Ca (DRUG).
Who is sponsoring clinical trial NCT00918645?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.